Indicators

Latest News about LEGN

Recent news which mentions LEGN

< Previous 1 2 3 4 Next >

NexImmune Pauses Developing Multiple Myeloma Hopeful, Citing Competition

August 16, 2022

PayPal, Alphabet And Some Other Big Stocks Recording Gains On Wednesday

July 28, 2022

Why Legend Biotech's Shares Jumped 11.8% on Wednesday

July 27, 2022

Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy

July 27, 2022

Walmart, Shopify And Some Other Big Stocks Recording Losses On Tuesday

July 27, 2022

Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate

July 26, 2022

12 Health Care Stocks Moving In Monday's After-Market Session

July 25, 2022

Short Volatility Alert: Legend Biotech Corporation

June 24, 2022

Legend Biotech Shares Move Higher After Bullish BMO Pitch

June 17, 2022

Short Volatility Alert: Legend Biotech Corporation

June 17, 2022

The Daily Biotech Pulse: Setback For NRx Pharma's COVID Study, Fast Track Tag For Pfizer's NASH Combo Therapy, Reata's Ataxia Drug In FDA Review

May 26, 2022

HFCAA News: 128 Chinese Stocks the SEC Could Delist

May 05, 2022

2 Biotechs With Recent FDA Approvals to Hold for the Next Decade

April 06, 2022

Most Chinese Biotech Stocks Can Continue US Listing After New Audit Framework

April 01, 2022

EMA's CHMP Clears Janssen, Legend's Multiple Myeloma CAR-T Therapy

March 25, 2022

Analyst Ratings For Legend Biotech

March 15, 2022

Benzinga's Top Ratings Upgrades, Downgrades For March 15, 2022

March 15, 2022

12 Health Care Stocks Moving In Monday's Pre-Market Session

March 14, 2022

The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg

March 06, 2022

Up 1,000% in 5 Years? These Healthcare Stocks Could Pull It Off.

March 04, 2022

GenScript Losses Widen, But Investors Focus on Newly Approved Cancer Treatment

March 01, 2022

The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution

March 01, 2022

FDA Approves JNJ-Legend Biotech Partnered Blood Cancer Therapy

March 01, 2022

The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight

February 27, 2022

FDA Slams Brakes On Legend Biotech's CAR-T Therapy Trial In Lymphoma Patients

February 15, 2022

Attention Biotech Investors: Mark Your Calendar For These Key February PDUFA Dates

February 01, 2022

Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2022

January 31, 2022

18 Stocks Moving in Thursday's Pre-Market Session

December 16, 2021

46 Biggest Movers From Yesterday

December 16, 2021

Why Legend Biotech Shares Plummeted 17.6% Wednesday

December 15, 2021

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.